Conversely, RA treatment was also reported to benefits tumor progression in sarcoma and chronic lymphocytic leukemia (CLL) by promoting the pro-tumoral differentiation of intertumoral monocytes in sarcoma and increasing CD38 expression in CLL cells (Chen et al., 2018; Devalaraja et al., 2020). This evidence concerns the gene CD38 and neoplasm.